Package Leaflet: Information for the User
Pirexin 20 mg/ml Oral Suspension
Ibuprofen
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Pirexin belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
This medicine is used for the symptomatic treatment of fever and pain of mild to moderate intensity.
Do not take Pirexin
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Pirexin. Special caution is recommended with Pirexin.
Tell your doctor:
Allergic Reactions
With ibuprofen, signs of allergic reaction to this medication have been reported, such as respiratory problems, swelling of the face and neck area (angioedema), and chest pain. Stop using Pirexin immediately and contact your doctor or the emergency medical service immediately if you notice any of these signs.
Cardiovascular Precautions
Anti-inflammatory/analgesic medications like ibuprofen may be associated with a small increased risk of suffering a heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking Pirexin if:
Similarly, this type of medication may cause fluid retention, especially in patients with heart failure and/or high blood pressure (hypertension).
Infections
Pirexin may hide the signs of an infection, such as fever and pain. Consequently, Pirexin may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medication while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
Skin Reactions
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), have been reported in association with ibuprofen treatment. Discontinue Pirexin treatment and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Precautions during Pregnancy and in Women of Childbearing Age
Because the administration of medications of the Pirexin type has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy unless it is considered strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
In the third trimester, the administration of Pirexin is contraindicated.
For women of childbearing age, it should be taken into account that medications of the Pirexin type have been associated with a decrease in fertility.
Using Pirexin with other Medications
Tell your doctor or pharmacist if you are using or have recently used any other medication, even those purchased without a prescription.
Pirexin may affect or be affected by other medications. For example:
Other medications may also affect or be affected by Pirexin treatment. Therefore, you should always consult your doctor or pharmacist before using Pirexin with other medications.
Interference with Laboratory Tests
Taking ibuprofen may alter the following laboratory tests:
Tell your doctor if you are going to undergo a clinical analysis and are taking or have recently taken ibuprofen.
Taking Pirexin with Food and Drinks
It is recommended to take Pirexin with milk or with food, or immediately after eating, to reduce the possibility of stomach upset.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take Pirexin during pregnancy, especially during the third trimester (see section precautions during pregnancy and in women of childbearing age).
Although only small amounts of the medication pass into breast milk, it is recommended not to take ibuprofen for prolonged periods during breastfeeding. It is not necessary to interrupt breastfeeding during short-term treatment with the recommended dose for pain and fever.
Driving and Using Machines
If you only take one dose of Pirexin or take it for a short period, it is not necessary to take special precautions.
If you experience dizziness, vertigo, vision disturbances, or other symptoms while taking this medication, do not drive or use hazardous machinery.
Pirexin contains azorubine (E-122), liquid maltitol (E-965), sodium benzoate (E-211), and sodium (as sodium benzoate, sodium citrate, sodium chloride, and sodium saccharin).
This medication:
Contains azorubine (E-122) which may cause allergic reactions. It can cause asthma, especially in patients allergic to acetylsalicylic acid.
Contains liquid maltitol (E-965). If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medication. It may have a slight laxative effect because it contains 2.5 g of liquid maltitol (E-965) per 5 ml dose. Caloric value: 2.3 kcal/g of maltitol.
Contains 1 mg of sodium benzoate (E-211) per ml. Sodium benzoate may increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks of age).
Contains less than 23 mg of sodium (1 mmol) per ml; this is, essentially "sodium-free".
Follow the administration instructions for this medication exactly as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Pirexin is an oral suspension. It can be administered directly or diluted in water.
For exact dosing, the packages contain a 5 ml oral syringe. The syringe is inserted into the perforated cap, the bottle is inverted, the plunger is pulled until the liquid reaches the corresponding milliliter (ml) mark, the bottle is returned to its initial position, and the syringe is removed.
The syringe should be cleaned and dried after each use.
Patients with stomach discomfort should take the medication with milk or during/after meals.
Children:
The dose of ibuprofen to be administered depends on the child's age and weight. As a general rule, the recommended daily dose is 20 to 30 mg per kg of weight, divided into three or four individual doses. It is recommended not to exceed the maximum daily dose of 40 mg per kg of weight of ibuprofen.
The use of this medication is not recommended in children under 3 months.
The interval between doses will depend on the evolution of symptoms, but it will never be less than 4 hours.
However, as a guideline, the following posology is recommended:
Age/Weight | Frequency | Dosage | Maximum daily dose |
Children from 3 to 6 months Approx. 5 to 7.6 kg | 3 times a day | 2.5 ml (50 mg) per dose | 7.5 ml (150 mg) |
Children from 6 to 12 months Approx. 7.7 to 9 kg | 3 to 4 times a day | 2.5 ml (50 mg) per dose | 7.5-10 ml (150-200 mg) |
Children from 1 to 3 years Approx. 10 to 15 kg | 3 to 4 times a day | 5 ml (100 mg) per dose | 15-20 ml (300-400 mg) |
Children from 4 to 6 years Approx. 16 to 20 kg | 3 to 4 times a day | 7.5 ml (150 mg) per dose | 22.5-30 ml (450-600 mg) |
Children from 7 to 9 years Approx. 21 to 29 kg | 3 to 4 times a day | 10 ml (200 mg) per dose | 30-40 ml (600-800 mg) |
Children from 10 to 12 years Approx. 30 to 40 kg | 3 to 4 times a day | 15 ml (300 mg) per dose | 45-60 ml (900-1200 mg) |
Adults and adolescents (over 12 years):
Due to the amount of ibuprofen contained in this medication, it is recommended to use other more suitable presentations for the treatment of adults and adolescents over 12 years.
Patients with kidney and/or liver disease:
If you have kidney and/or liver disease, your doctor may prescribe a lower dose than usual. If so, take the exact dose that your doctor has prescribed.
Elderly patients:
If you are over 60 years old, your doctor may prescribe a lower dose than usual. If so, you can only increase the dose once your doctor has checked that you tolerate the medication well.
The effective lowest dose should be used for the shortest necessary time to relieve symptoms. If you have an infection, consult your doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
If you think the action of this medication is too strong or too weak, inform your doctor or pharmacist.
If you take more Pirexin than you should
If you have taken more Pirexin than you should, or if a child has accidentally ingested the medication, consult your doctor or go to the nearest hospital immediately to find out about the risk and ask for advice on the measures to be taken.
Overdose symptoms may include nausea, stomach pain, vomiting (which may contain bloody sputum), gastrointestinal bleeding (see also section 4), diarrhea, headache, ringing in the ears, confusion, and involuntary eye movement. Agitation, drowsiness, disorientation, or coma may also occur. Occasionally, patients develop seizures. At high doses, symptoms of numbness, chest pain, palpitations, loss of consciousness, seizures (mainly in children), weakness, and dizziness, blood in the urine, low potassium levels in the blood, chills, and breathing problems have been reported. Additionally, the prothrombin time with INR may be prolonged, probably due to interference with the actions of circulating coagulation factors. Acute kidney failure and liver damage may occur. Exacerbation of asthma is possible in asthmatics. There may also be low blood pressure and reduced breathing.
If a severe poisoning has occurred, the doctor will take the necessary measures.
In case of ingestion of significant amounts, activated charcoal should be administered. Stomach emptying will be considered if significant amounts have been ingested and within 60 minutes after ingestion.
If you forget to take Pirexin
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time of the next dose is very close, skip the forgotten dose and take the next dose at its usual time.
Like all medications, this medication can cause side effects, although not everyone will experience them.
The side effects of medications like Pirexin are more common in people over 65 years old.
The incidence of side effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
Frequencies are established according to the following classification: very frequent (in more than 1 in 10 patients); frequent (between 1 and 10 in 100 patients); uncommon (between 1 and 10 in 1,000 patients); rare (between 1 and 10 in 10,000 patients); very rare (in less than 1 in 10,000 patients); frequency not known (cannot be estimated from available data).
The following side effects have been observed:
Gastrointestinal:
The most frequent side effects that occur with medications like Pirexin are gastrointestinal: peptic ulcers, gastrointestinal bleeding, perforations (in some cases fatal), especially in elderly patients. Nausea, vomiting, diarrhea, flatulence, constipation, heartburn, abdominal pain, blood in stools, vomiting blood, oral ulcers, worsening of ulcerative colitis and Crohn's disease (a chronic disease in which the immune system attacks the intestine, causing inflammation that usually produces diarrhea with blood) have also been observed.
Gastritis has been observed less frequently.
Other side effects are: Uncommon: inflammation of the oral mucosa with ulcer formation. Rare: esophageal inflammation, esophageal stricture, worsening of diverticular disease, hemorrhagic colitis. Very rare: pancreatitis.
Cardiovascular:
Medications like Pirexin may be associated with a moderate increase in the risk of suffering a heart attack or stroke.
Edema, hypertension, and heart failure have also been observed in association with treatments with medications of the Pirexin type.
Chest pain, which can be a sign of a potentially serious allergic reaction called Kounis syndrome.
Dermatological:
Medications like Pirexin may be associated, in very rare cases, with severe blistering reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis.
Other side effects are: Frequent: skin rash. Uncommon: skin redness, itching or skin swelling, purpura. Very rare: hair loss, erythema multiforme, skin reactions due to light influence, inflammation of skin blood vessels. Exceptionally, severe skin infections and soft tissue complications can occur during chickenpox. Unknown frequency: skin becomes sensitive to light, a severe skin reaction known as DRESS syndrome can also occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils.
Generalized red scaly rash, with bumps under the skin and blisters, mainly on the skin folds, trunk, and upper limbs, accompanied by fever at the start of treatment. Stop taking Pirexin if you experience these symptoms and seek medical attention immediately. See also section 2.
Immune system:
Uncommon: transient edema in areas of the skin, mucous membranes, or sometimes in viscera, nasal mucosa inflammation, bronchospasm. Rare: severe allergic reactions. In case of generalized severe hypersensitivity reaction, facial swelling, tongue and larynx swelling, bronchospasm, asthma, tachycardia, hypotension, and shock may appear. Very rare: joint pain and fever.
Nervous system:
Frequent: fatigue or drowsiness, headache, and dizziness or instability. Rare: paresthesia. Very rare: aseptic meningitis.
Psychiatric:
Uncommon: insomnia, anxiety, restlessness. Rare: disorientation or confusion, nervousness, irritability, depression, psychotic reaction.
Auditory:
Frequent: vertigo. Uncommon: ringing or buzzing in the ears. Rare: hearing difficulty.
Ocular:
Uncommon: vision changes. Rare: abnormal or blurred vision.
Blood:
Rare: decreased platelets, decreased white blood cells, decreased red blood cells, decreased granulocytes, pancytopenia, agranulocytosis, aplastic anemia, or hemolytic anemia. The first symptoms are: fever, sore throat, superficial ulcers in the mouth, pseudo-flu symptoms, extreme fatigue, nosebleeds, and skin bleeding. Very rare: prolonged bleeding time.
Renal:
Based on experience with NSAIDs in general, cases of interstitial nephritis, nephrotic syndrome, and renal failure cannot be excluded.
Hepatic:
Medications like Pirexin may be associated, in rare cases, with liver damage. Other rare side effects are: hepatitis, abnormal liver function, and jaundice. Unknown frequency: liver failure.
General:
Worsening of inflammation during infectious processes.
To date, no serious allergic reactions have been reported with Pirexin, although they cannot be ruled out. The manifestations of this type of reaction could be fever, skin rash, abdominal pain, severe and persistent headache, nausea, vomiting, facial swelling, tongue and throat swelling, difficulty breathing, asthma, palpitations, hypotension, or shock.
If any of the following side effects occur, stop treatment and go to your doctor immediately:
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not store at a temperature above 25°C.
Do not use this medication after the expiration date that appears on the packaging after "CAD". The expiration date is the last day of the month indicated.
Medications should not be thrown away through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Pirexin composition
Product appearance and packaging contents
Bottle made of topaz PET containing an oral suspension of pink color, with a strawberry odor and flavor.
It includes a 5 ml oral syringe.
It is presented in packages containing 200 and 150 ml of oral suspension.
Only some package sizes may be marketed.
Other available presentations
Pirexin 40 mg/ml in a 150 ml package.
Marketing authorization holder and manufacturer
Holder:
Laboratorios ERN, S.A.
C/Perú, 228
08020 Barcelona, Spain.
Manufacturer:
Industria Química y Farmacéutica VIR, S.A.
C/Laguna 66-70, Polígono Industrial URTINSA II
28923 Alcorcón (Madrid) - Spain.
Date of the last revision of this leaflet: October 2024.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.